Skip to main content
×
×
Home

Evaluating the relationship of high-dose venlafaxine prescribing to treatment-resistant depression

  • Arwel Thomas (a1) and David Taylor (a1)
Abstract
Aims and Method

Prescribing of venlafaxine in The South London and Maudsley NHS Trust was found to account for over 50% of the antidepressant costs, but only 15% of the prescriptions. There is evidence to suggest that higher doses of venlafaxine may be effective in treating treatment-refractory depression. We aimed to discover if higher doses of venlafaxine used in the trust were related to prior failure to respond to antidepressant treatment. Hospital in-patients being treated with venlafaxine during a 1-week period in October 2001 were identified and case notes were reviewed to determine patient demographic data and prior history of antidepressant therapy.

Results

There were 38 patients identified as being prescribed venlafaxine (18 of whom had a primary diagnosis of depression). Twenty-five were classed as non-treatment-resistant and 13 were classed as treatment-resistant. Doses of venlafaxine were statistically significantly higher in patients considered treatment-resistant (245 mg v. 180 mg daily, P=0.03). All other recorded patient characteristics were similar.

Clinical Implications

Higher doses of venlafaxine were prescribed to patients who were retrospectively defined as treatment-refractory. Further studies should address the reasons for this prescribing practice.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Evaluating the relationship of high-dose venlafaxine prescribing to treatment-resistant depression
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Evaluating the relationship of high-dose venlafaxine prescribing to treatment-resistant depression
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Evaluating the relationship of high-dose venlafaxine prescribing to treatment-resistant depression
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Association of The British Pharmaceutical Industry (2002) Medicines Compendium. London: Datapharm Communications.
Clerc, G. E., Ruimy, P & Verdeaupailles, J. (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalised for major depression and melancholia. International Clinical Psychopharmacology, 9, 139143.
Dierick, M., Ravizza, L., Realini, R., et al. (1996) A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 20, 5771.
Gentil, V., Kerr-Correa, F., Moreno, R., et al (2000) Double blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia. Journal of Psychopharmacolgy, 14, 6166.
Harvey, A.T., Rudolph, R. L. & Preskorn, S. H. (2000) Evidence of the dual mechanisms of action of venlafaxine. Archives of General Psychiatry, 57, 503509.
Khan, A., Upton, G. V., Rudolph, R. L., et al (1998) The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose–response study. Journal of Clinical Psychopharmacology, 18, 1925.
Nierenberg, A. A., Feighner, J. P., Rudolph, R., et al (1994) Venlafaxine for treatment-resistant unipolar depression. Journal of Clinical Psychopharmacology, 14, 419423.
Poirier, M. F. & Boyer, P. (1999) Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. British Journal of Psychiatry, 175, 1216.
Schweizer, E., Weise, C., Clary, C., et al (1991) Placebo-controlled trial of venlafaxine for the treatment of major depression. Journal of Clinical Psychopharmacology, 11, 233236.
Shrivastava, R. K., Cohn, C., Crowder, J., et al (1994) Long term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. Journal of Clinical Psychopharmacology, 14, 322329.
Smith, D., Dempster, C., Glanville, J., et al (2002) Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. British Journal of Psychiatry, 180, 396404.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 2
Total number of PDF views: 10 *
Loading metrics...

Abstract views

Total abstract views: 107 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 17th July 2018. This data will be updated every 24 hours.

Evaluating the relationship of high-dose venlafaxine prescribing to treatment-resistant depression

  • Arwel Thomas (a1) and David Taylor (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *